Doctors Note Logo

Published on: 5/19/2026

Understanding Viral Classifications: The Genomic Science of Orthohantaviruses

Orthohantaviruses are enveloped, segmented negative-sense RNA viruses in the order Bunyavirales (genus Orthohantavirus) whose three genome segments encode an RNA polymerase, two surface glycoproteins and a nucleocapsid protein and which cause hantavirus pulmonary syndrome in the Americas and hemorrhagic fever with renal syndrome in Europe and Asia. These viruses coevolve with specific rodent reservoirs and infect humans primarily through inhalation of aerosolized excreta.

There are several factors to consider including clinical syndromes, diagnostic methods, treatment options and prevention measures that can critically influence your next steps, so see below for more details.

answer background

Explanation

Understanding Viral Classifications: The Genomic Science of Orthohantaviruses

Orthohantaviruses are a group of viruses best known for causing serious human illnesses such as hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). They belong to the larger Hantavirus virus family Bunyaviridae, a diverse family of RNA viruses. This article unpacks their classification, genome structure, evolution, reservoirs, transmission, and what you need to know about prevention and early detection.

  1. Viral Taxonomy and Classification
    Viruses are classified based on their genetic material, structure, and replication strategy. Orthohantaviruses have historically been placed in:
  • Order: Bunyavirales
  • Family: Bunyaviridae (in older systems)
  • Genus: Orthohantavirus

Key points:

  • "Bunyaviridae" refers to a broad group of enveloped viruses with segmented RNA genomes.
  • Orthohantaviruses share this segmented genome and similar replication patterns.
  • Modern taxonomy may place hantaviruses in the family Hantaviridae within the order Bunyavirales, but the term "Bunyaviridae" remains common in the literature.
  1. Genome Organization
    Orthohantaviruses have a single-stranded, negative-sense RNA genome divided into three segments:

• L segment (large)
– Encodes the viral RNA-dependent RNA polymerase (RdRp).
– Critical for viral replication and transcription.

• M segment (medium)
– Encodes two surface glycoproteins, Gn and Gc.
– These glycoproteins mediate attachment to host cells and entry.

• S segment (small)
– Encodes the nucleocapsid (N) protein.
– Protects the viral RNA and assists in genome packaging.

Segmented genomes allow for genetic reassortment if a single cell is co-infected by two different strains—potentially generating new variants.

  1. Evolution and Phylogeny
    Orthohantaviruses have co-evolved with their rodent or insectivore hosts over millions of years. Molecular studies show:

• Host co-divergence
– Each hantavirus species tends to be associated with a specific rodent or shrew species.
– Over time, the virus and its host lineage have evolved together.

• Geographic segregation
– New World hantaviruses (Americas) often cause HPS.
– Old World hantaviruses (Europe, Asia) are linked to HFRS.

• Genetic reassortment potential
– Rare but important when two strains infect the same host.
– Can drive the emergence of strains with altered virulence or host range.

  1. Natural Reservoirs and Transmission
    Unlike many other zoonotic viruses, orthhantaviruses are not transmitted from person to person (with a few rare exceptions). Main points:

• Rodent hosts
– Deer mice, cotton rats, bank voles, and other rodents carry specific hantavirus species.
– Infected rodents shed virus in urine, droppings, and saliva.

• Human exposure
– Inhalation of aerosolized viral particles in rodent-contaminated environments.
– Direct contact with rodent excreta or bites (rare).
– No confirmed vector-borne or fomite transmission beyond rodent–human interaction.

• Environmental risk factors
– Cleaning out barns, sheds, or cabins.
– Disturbing rodent nests or droppings in enclosed spaces.
– Occupations or activities with rodent exposure (farmwork, field research, pest control).

  1. Clinical Syndromes
    Orthohantaviruses are best known for two major clinical presentations:

A. Hantavirus Pulmonary Syndrome (HPS)
– Predominantly in the Americas.
– Sudden onset of fever, muscle aches, and fatigue.
– Rapid progression to cough, shortness of breath, and fluid buildup in lungs.
– Can lead to life-threatening respiratory failure.

B. Hemorrhagic Fever with Renal Syndrome (HFRS)
– Primarily in Europe and Asia.
– Phases: febrile, hypotensive, oliguric (reduced urine output), diuretic, convalescent.
– Symptoms include high fever, abdominal pain, back pain, blurred vision, low blood pressure, and acute kidney injury.
– Severity ranges from mild to fatal depending on virus species.

Common early symptoms (both syndromes):

  • Fever and chills
  • Headache
  • Muscle or back pain
  • Nausea, vomiting, or diarrhea
  1. Diagnosis and Laboratory Testing
    Early recognition is crucial. Diagnostic approaches include:

• Serology
– Detects antibodies (IgM, IgG) against hantavirus antigens.
– IgM appears early in infection; IgG rises later.

• Molecular tests
– RT-PCR on blood or tissue samples to detect viral RNA.
– Useful in early acute phase.

• Clinical criteria
– Travel or exposure history.
– Compatible symptoms and lab findings (thrombocytopenia, elevated hematocrit, renal dysfunction).

If you're experiencing any of these concerning symptoms and need immediate guidance, try this free Medically approved LLM Symptom Checker Chat Bot to help you understand your symptoms and determine if urgent medical care is needed.

  1. Treatment and Management
    No specific antiviral treatment is universally approved for orthhantavirus infections, but supportive care is vital:

• Hospitalization
– Monitoring in an intensive care unit if respiratory or renal failure develops.

• Respiratory support
– Oxygen therapy, mechanical ventilation for HPS respiratory distress.

• Fluid management
– Careful balance to avoid fluid overload in lungs yet maintain kidney perfusion in HFRS.

• Renal support
– Dialysis may be required during the oliguric phase of HFRS.

Ribavirin, an antiviral drug, has shown some benefit in reducing mortality in HFRS if given early, though its efficacy in HPS remains unclear.

  1. Prevention Strategies
    Since there is no widespread vaccine for most hantaviruses, prevention focuses on limiting rodent exposure:

• Rodent-proof your home
– Seal holes or gaps larger than 1/4 inch.
– Store food in rodent-proof containers.

• Safe cleanup of rodent droppings
– Ventilate enclosed spaces for at least 30 minutes.
– Wear gloves and a mask (ideally N95).
– Wet surfaces with a disinfectant or bleach solution before cleaning.

• Reduce rodent harborages
– Keep woodpiles and debris away from buildings.
– Eliminate rodent nesting sites in and around structures.

• Public health measures
– Surveillance of rodent populations.
– Education on safe agricultural and recreational practices in endemic areas.

  1. Public Health and Research Directions
    Ongoing research aims to:
  • Develop effective vaccines and antivirals.
  • Understand viral evolution and potential for new strains.
  • Map rodent reservoir distributions and human risk areas.
  • Improve rapid diagnostics for early detection.

Conclusion
Orthohantaviruses, members of the Hantavirus virus family Bunyaviridae, are complex zoonotic pathogens with segmented RNA genomes. They circulate in rodent hosts worldwide and can cause severe, sometimes fatal, human disease. Awareness of risk factors, early symptom recognition, and prompt medical evaluation are essential.

If you've been exposed to rodents or are experiencing fever, muscle aches, breathing difficulties, or any other worrying symptoms, get immediate help by using this Medically approved LLM Symptom Checker Chat Bot to assess your symptoms and understand when to seek emergency care. Always speak to a doctor about anything that could be life-threatening or serious.

(References)

  • * Plyusnin A, Sironen T, Henttonen H. Orthohantaviruses: genetic diversity, evolution, and pathogenesis. Curr Top Microbiol Immunol. 2013;372:1-26. doi: 10.1007/978-3-642-30275-2_1. PMID: 23292415.

  • * Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantaviruses: an overview of their classification, evolution, and genetic characteristics. Infect Dis Poverty. 2014 Dec 11;3(1):15. doi: 10.1186/2049-9957-3-15. PMID: 25497042; PMCID: PMC4267433.

  • * Kang HJ, Kim WK, Cho HW, Kim JS, Song JW. Genomic organization and evolution of hantaviruses. Viruses. 2011 May;3(5):548-61. doi: 10.3390/v3050548. Epub 2011 May 26. PMID: 21666838; PMCID: PMC3111048.

  • * Plyusnin A. Phylogenetic analysis of hantaviruses. Methods Mol Biol. 2011;704:57-73. doi: 10.1007/978-1-61779-001-2_4. PMID: 21107572.

  • * Saksida A. The impact of next-generation sequencing on hantavirus research. Virol J. 2019 Jun 27;16(1):82. doi: 10.1186/s12985-019-1191-3. PMID: 31248443; PMCID: PMC6599307.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.